Intangibles (Net)
Eli Lilly Intangibles (Net) increased by 13.1% to $7.37B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.7%, from $6.01B to $7.37B. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows a downward trend with a -2.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase typically signals recent acquisitions of intellectual property or drug candidates, while a decrease reflects ongoing amortization or potential impairment.
Detailed definition
This represents the net book value of non-physical assets such as patents, trademarks, licenses, and acquired intellectu...
Peer comparison
High in R&D-heavy industries like pharmaceuticals, where intellectual property is the primary driver of future revenue.
intangible_assets_netHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.99B | $7.89B | $7.69B | $7.48B | $7.50B | $7.12B | $7.21B | $7.09B | $6.90B | $6.78B | $6.91B | $6.76B | $6.64B | $6.54B | $6.17B | $6.01B | $5.91B | $6.45B | $6.52B | $7.37B |
| QoQ Change | — | -1.2% | -2.5% | -2.7% | +0.2% | -5.0% | +1.2% | -1.7% | -2.6% | -1.8% | +1.8% | -2.1% | -1.9% | -1.5% | -5.7% | -2.5% | -1.7% | +9.1% | +1.2% | +13.1% |
| YoY Change | — | — | — | — | -6.1% | -9.7% | -6.3% | -5.3% | -7.9% | -4.8% | -4.2% | -4.6% | -3.9% | -3.6% | -10.7% | -11.1% | -11.0% | -1.4% | +5.8% | +22.7% |
Intangibles (Net) at Other Companies
Frequently Asked Questions
- What is Eli Lilly's intangibles (net)?
- Eli Lilly (LLY) reported intangibles (net) of $7.37B in Q1 2026.
- How has Eli Lilly's intangibles (net) changed year-over-year?
- Eli Lilly's intangibles (net) increased by 22.7% year-over-year, from $6.01B to $7.37B.
- What is the long-term trend for Eli Lilly's intangibles (net)?
- Over 5 years (2020 to 2025), Eli Lilly's intangibles (net) has grown at a -2.6% compound annual growth rate (CAGR), from $7.45B to $6.52B.
- What does intangibles (net) mean?
- The net value of non-physical assets like patents, licenses, and intellectual property.